DLUEY yields 103.57% · JNJ yields 2.13%● Live data
📍 DLUEY pulled ahead of the other in Year 1
Combined, DLUEY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DLUEY + JNJ for your $10,000?
De La Rue plc designs, manufactures, and delivers banknotes in the United Kingdom, the Middle East, Africa, Asia, the Americas, Rest of Europe, and internationally. It operates through Currency, Authentication, and Identity Solutions. The company offers printed banknotes, and polymer and security features. It also provides range of physical solutions, such as tax stamps, authentication labels, and cheques and bank cards, as well as ID security components, including polycarbonate. In addition, it offers digital solutions, such as DLR Certify, a government revenue solution; and Tracelogy for brand protection, as well as licensing platform. Further, the company provides trading and non-trading, as well as insurance services. It serves the governments, central banks, and commercial organizations. The company was founded in 1813 and is headquartered in Basingstoke, the United Kingdom.
Full DLUEY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.